New nanocarrier drug delivery technology crosses the blood-brain barrier

The blood-brain barrier (BBB) makes it more difficult for substances to be delivered from the blood to the brain compared to peripheral organs. Japanese researchers have developed a cyclic peptide that enhances BBB penetration. By putting drugs into nanoparticles that have the cyclic peptide on their surface, new drug nanocarriers may be developed for the delivery to the brain.